1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Beta-2 Receptors Antagonists -Pipeline Insights, 2015

Summary


DelveInsight’s, Beta-2 Receptors Antagonists- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Beta-2 Receptors Antagonists. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Beta-2 Receptors Antagonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

DelveInsight’s, Beta-2 Receptors Antagonists- Pipeline Insights, 2015 Report covers the Beta-2 Receptors Antagonists pipeline molecules at various stages of development like Pre-registration phase, clinical phases (Phase III, Phase II & Phase I), pre-clinical and discovery phases. The Report also provides Beta-2 Receptors Antagonists related therapeutic assessments by molecule type, route of administration, monotherapy and combination products. The Report also highlights the discontinued and inactive projects in pipeline for Beta-2 Receptors Antagonists.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


Scope


- DelveInsight’s report provides a Beta-2 Receptors Antagonists Landscape across the globe
- The report provides drug profiles which includes product description, MOA, licensors & collaborators, technology, development partner and chemical information
- Coverage of the Beta-2 Receptors Antagonists pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Beta-2 Receptors Antagonists and also provide company profiling
- Pipeline products coverage based on various stages of development from NDA filings to discovery.
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


Reasons to Buy


- Complete Pipeline intelligence and complete understanding over therapeutics development for Beta-2 Receptors Antagonists
- Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
- Track your competitors and develop strategic initiatives to support your drug development activities.
- Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
- Understand the market and choose right partners for in-licensing and out licensing for your valuable assets
- Understand the factors behind failed/discontinued projects and move ahead without leaving any stone unturned

Table Of Contents

Beta-2 Receptors Antagonists -Pipeline Insights, 2015
List of Tables

• Number of Products under Development for Beta-2 Receptors Antagonists by Therapy Area, 2015
• Number of Products under Development for Beta-2 Receptors Antagonists, 2015
• Number of Products under Development by Companies
• Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2015
• Comparative Analysis Mid Clinical Stage Products (Phase II), 2015
• Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2015
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2015
• Drug Candidates Profiles
• Beta-2 Receptors Antagonists Assessment by Monotherapy Products
• Beta-2 Receptors Antagonists Assessment by Combination Products
• Beta-2 Receptors Antagonists Assessment by Route of Administration
• Beta-2 Receptors Antagonists Assessment by Stage and Route of Administration
• Beta-2 Receptors Antagonists Assessment by Molecule Type
• Beta-2 Receptors Antagonists Assessment by Stage and Molecule Type
• Beta-2 Receptors Antagonists Therapeutics - Discontinued Products
• Beta-2 Receptors Antagonists Therapeutics - Dormant Products
• Products under Development by Companies, 2015

List of Figures

• Number of Products under Development for Beta-2 Receptors Antagonists by Therapy Area, 2015
• Number of Products under Development for Beta-2 Receptors Antagonists, 2015
• Late Clinical Stage Products (Filed and Phase III), 2015
• Mid Clinical Stage Products (Phase II), 2015
• Early Clinical Stage Products (Phase I and IND Filed), 2015
• Discovery and Pre-Clinical Stage Products, 2015
• Beta-2 Receptors Antagonists Assessment by Monotherapy Products
• Beta-2 Receptors Antagonists Assessment by Combination Products
• Beta-2 Receptors Antagonists Assessment by Route of Administration
• Beta-2 Receptors Antagonists Assessment by Stage and Route of Administration
• Beta-2 Receptors Antagonists Assessment by Molecule Type
• Beta-2 Receptors Antagonists Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market in Europe

  • November 2016
    19 pages
  • Therapy  

  • Europe  

View report >

Therapy Market and Hypertension Statistics in Asia and the US

  • November 2016
    26 pages
  • Therapy  

    Hypertension  

    Cardiovascular ...  

  • Asia  

    United States  

    Europe  

View report >

Therapy Market in the US - Forecast

  • November 2016
    6 pages
  • Therapy  

    Opioid  

  • United States  

View report >

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.